These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 23881925)

  • 1. Protein kinase C-δ-mediated recycling of active KIT in colon cancer.
    Park M; Kim WK; Song M; Park M; Kim H; Nam HJ; Baek SH; Kim H
    Clin Cancer Res; 2013 Sep; 19(18):4961-71. PubMed ID: 23881925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. c-Kit is suppressed in human colon cancer tissue and contributes to L1-mediated metastasis.
    Gavert N; Shvab A; Sheffer M; Ben-Shmuel A; Haase G; Bakos E; Domany E; Ben-Ze'ev A
    Cancer Res; 2013 Sep; 73(18):5754-63. PubMed ID: 24008320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The molecular chaperone Cosmc enhances malignant behaviors of colon cancer cells via activation of Akt and ERK.
    Huang J; Che MI; Lin NY; Hung JS; Huang YT; Lin WC; Huang HC; Lee PH; Liang JT; Huang MC
    Mol Carcinog; 2014 Feb; 53 Suppl 1():E62-71. PubMed ID: 23390052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. KIT/stem cell factor expression in premalignant and malignant lesions of the colon mucosa in relationship to disease progression and outcomes.
    Bellone G; Smirne C; Carbone A; Buffolino A; Scirelli T; Prati A; Solerio D; Pirisi M; Valente G; Nano M; Emanuelli G
    Int J Oncol; 2006 Oct; 29(4):851-9. PubMed ID: 16964380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metastatic function of BMP-2 in gastric cancer cells: the role of PI3K/AKT, MAPK, the NF-κB pathway, and MMP-9 expression.
    Kang MH; Oh SC; Lee HJ; Kang HN; Kim JL; Kim JS; Yoo YA
    Exp Cell Res; 2011 Jul; 317(12):1746-62. PubMed ID: 21570392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. c-Kit is preferentially expressed in MYCN-amplified neuroblastoma and its effect on cell proliferation is inhibited in vitro by STI-571.
    Vitali R; Cesi V; Nicotra MR; McDowell HP; Donfrancesco A; Mannarino O; Natali PG; Raschellà G; Dominici C
    Int J Cancer; 2003 Aug; 106(2):147-52. PubMed ID: 12800187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The stem cell factor/c-kit receptor pathway enhances proliferation and invasion of pancreatic cancer cells.
    Yasuda A; Sawai H; Takahashi H; Ochi N; Matsuo Y; Funahashi H; Sato M; Okada Y; Takeyama H; Manabe T
    Mol Cancer; 2006 Oct; 5():46. PubMed ID: 17044945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stem cell factor/c-kit receptor signaling enhances the proliferation and invasion of colorectal cancer cells through the PI3K/Akt pathway.
    Yasuda A; Sawai H; Takahashi H; Ochi N; Matsuo Y; Funahashi H; Sato M; Okada Y; Takeyama H; Manabe T
    Dig Dis Sci; 2007 Sep; 52(9):2292-300. PubMed ID: 17410437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Haematopoietic progenitor cells utilise conventional PKC to suppress PKB/Akt activity in response to c-Kit stimulation.
    Edling CE; Pedersen M; Carlsson L; Rönnstrand L; Palmer RH; Hallberg B
    Br J Haematol; 2007 Jan; 136(2):260-8. PubMed ID: 17156394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early myeloid cells expressing c-KIT isoforms differ in signal transduction, survival and chemotactic responses to Stem Cell Factor.
    Young SM; Cambareri AC; Odell A; Geary SM; Ashman LK
    Cell Signal; 2007 Dec; 19(12):2572-81. PubMed ID: 17855052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stem cell factor attenuates vascular smooth muscle apoptosis and increases intimal hyperplasia after vascular injury.
    Wang CH; Verma S; Hsieh IC; Hung A; Cheng TT; Wang SY; Liu YC; Stanford WL; Weisel RD; Li RK; Cherng WJ
    Arterioscler Thromb Vasc Biol; 2007 Mar; 27(3):540-7. PubMed ID: 17204664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of AKT signaling promotes epithelial-mesenchymal transition and tumor growth in colorectal cancer cells.
    Suman S; Kurisetty V; Das TP; Vadodkar A; Ramos G; Lakshmanaswamy R; Damodaran C
    Mol Carcinog; 2014 Feb; 53 Suppl 1():E151-60. PubMed ID: 24000138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maintenance of Clonogenic KIT(+) Human Colon Tumor Cells Requires Secretion of Stem Cell Factor by Differentiated Tumor Cells.
    Fatrai S; van Schelven SJ; Ubink I; Govaert KM; Raats D; Koster J; Verheem A; Borel Rinkes IH; Kranenburg O
    Gastroenterology; 2015 Sep; 149(3):692-704. PubMed ID: 25962936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. KIT receptor activation by autocrine and paracrine stem cell factor stimulates growth of merkel cell carcinoma in vitro.
    Krasagakis K; Fragiadaki I; Metaxari M; Krüger-Krasagakis S; Tzanakakis GN; Stathopoulos EN; Eberle J; Tavernarakis N; Tosca AD
    J Cell Physiol; 2011 Apr; 226(4):1099-109. PubMed ID: 20857409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RabGEF1 regulates stem cell factor/c-Kit-mediated signaling events and biological responses in mast cells.
    Kalesnikoff J; Rios EJ; Chen CC; Nakae S; Zabel BA; Butcher EC; Tsai M; Tam SY; Galli SJ
    Proc Natl Acad Sci U S A; 2006 Feb; 103(8):2659-64. PubMed ID: 16533754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stem cell factor augments Fc epsilon RI-mediated TNF-alpha production and stimulates MAP kinases via a different pathway in MC/9 mast cells.
    Ishizuka T; Kawasome H; Terada N; Takeda K; Gerwins P; Keller GM; Johnson GL; Gelfand EW
    J Immunol; 1998 Oct; 161(7):3624-30. PubMed ID: 9759885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and molecular evidence for c-kit receptor as a therapeutic target in neuroblastic tumors.
    Uccini S; Mannarino O; McDowell HP; Pauser U; Vitali R; Natali PG; Altavista P; Andreano T; Coco S; Boldrini R; Bosco S; Clerico A; Cozzi D; Donfrancesco A; Inserra A; Kokai G; Losty PD; Nicotra MR; Raschellà G; Tonini GP; Dominici C
    Clin Cancer Res; 2005 Jan; 11(1):380-9. PubMed ID: 15671569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CUB domain-containing protein 1, a prognostic factor for human pancreatic cancers, promotes cell migration and extracellular matrix degradation.
    Miyazawa Y; Uekita T; Hiraoka N; Fujii S; Kosuge T; Kanai Y; Nojima Y; Sakai R
    Cancer Res; 2010 Jun; 70(12):5136-46. PubMed ID: 20501830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Src family kinase activity is required for Kit-mediated mitogen-activated protein (MAP) kinase activation, however loss of functional retinoblastoma protein makes MAP kinase activation unnecessary for growth of small cell lung cancer cells.
    Bondzi C; Litz J; Dent P; Krystal GW
    Cell Growth Differ; 2000 Jun; 11(6):305-14. PubMed ID: 10910097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High expression of proline-rich tyrosine kinase 2 is associated with poor survival of hepatocellular carcinoma via regulating phosphatidylinositol 3-kinase/AKT pathway.
    Cao J; Chen Y; Fu J; Qian YW; Ren YB; Su B; Luo T; Dai RY; Huang L; Yan JJ; Wu MC; Yan YQ; Wang HY
    Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S312-23. PubMed ID: 22618716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.